A mixed-methods analysis of patient safety incidents involving opioid substitution treatment with methadone or buprenorphine in community-based care in England and Wales.

Addiction
Russell GibsonAndrew Carson-Stevens

Abstract

Opioid substitution treatment is used in many countries as an effective harm minimization strategy. There is a need for more information about patient safety incidents and the resulting harm relating to this treatment. We aimed to characterize patient safety incidents involving opioid substitution treatment with methadone or buprenorphine in community-based care by: (i) identifying the sources and nature of harm and (ii) describing and interpreting themes to identify priorities to focus future improvement work. Mixed-methods study examining patient safety incident reports involving opioid substitution treatment with either methadone or buprenorphine in community-based care. Data submitted between 2005 and 2015 from the National Reporting and Learning System (NRLS), a national repository of patient safety incident reports from across England and Wales. A total of 2284 reports were identified involving patients receiving community-based opioid substitution treatment. Incident type, contributory factors, incident outcome and severity of harm. Analysis involved data coding, processing and iterative generation of data summaries using descriptive statistical and thematic analysis. Most risks of harm from opioid substitution treatment...Continue Reading

References

Nov 12, 2005·Substance Use & Misuse·Alessandra Buonopane, Ismene L Petrakis
Jan 16, 2007·BMJ : British Medical Journal·Charles Vincent
Jan 17, 2009·International Journal for Quality in Health Care : Journal of the International Society for Quality in Health Care·UNKNOWN World Alliance For Patient Safety Drafting GroupMartti Virtanen
Aug 27, 2009·Therapeutics and Clinical Risk Management·Laura J DickeyJack D Sobel
Feb 3, 2011·BMC Medical Informatics and Decision Making·Liang XiaoBorislav D Dimitrov
Jun 2, 2011·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Matthew Grissinger, Michael J Gaunt
Apr 25, 2012·International Journal of Clinical Pharmacy·Mara Pereira GuerreiroJudith Anne Cantrill
Jan 1, 2011·The Australasian Medical Journal·B B ChaarC Day
Nov 6, 2013·Journal of Addiction Medicine·Louis E BaxterBonnie B Wilford
Jan 13, 2015·Annual Review of Public Health·Andrew KolodnyG Caleb Alexander
May 15, 2015·Integrative and Comparative Biology·Ariel L Camp, Elizabeth L Brainerd
Jul 2, 2015·Euro Surveillance : Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin·C M GossnerUNKNOWN European Food and Waterborne Diseases Study Group
Oct 16, 2015·Journal of Addictive Diseases·Christine TimkoChristina Garrison-Diehn
May 10, 2016·The Cochrane Database of Systematic Reviews·Suzanne NielsenNicholas Lintzeris
Nov 20, 2016·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Stefan G Kertesz
Apr 12, 2017·BMC Medical Informatics and Decision Making·Jessica S AnckerUNKNOWN with the HITEC Investigators
Apr 28, 2017·BMJ : British Medical Journal·Luis SordoRoberto Pastor-Barriuso
Apr 28, 2017·BMJ : British Medical Journal·Ajay ManhapraDavid A Fiellin
May 4, 2017·Lancet·Liam J DonaldsonAziz Sheikh
Jul 5, 2018·The New England Journal of Medicine·Sarah E Wakeman, Michael L Barnett
Aug 1, 2018·Health & Social Care in the Community·Alexandra Chapman
Dec 6, 2018·JAMA Psychiatry·Nora D VolkowEric M Wargo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.